Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-06-14

Clinical Trial Update: Markers of T Cell Suppression: Associations With Malaria Infection and Antimalarial Treatment in Malian Children

View source ↗

Summary

A completed clinical trial update examining how malaria infection and antimalarial treatment relate to markers of T cell suppression in Malian children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Malaria | Status: COMPLETED